Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitors |
| |
| Authors: | Rosanna Tedesco Deping Chai Michael G. Darcy Dashyant Dhanak Duke M. Fitch Adam Gates Victor K. Johnston Richard M. Keenan Juili Lin-Goerke Robert T. Sarisky Antony N. Shaw Klara L. Valko Kenneth J. Wiggall Michael N. Zimmerman Kevin J. Duffy |
| |
| Affiliation: | 1. Department of Medicinal Chemistry, GlaxoSmithKline Pharmaceuticals, Collegeville, PA 19426, USA;2. Department of Virology, GlaxoSmithKline Pharmaceuticals, Collegeville, PA 19426, USA;3. Department of Analytical Sciences, GlaxoSmithKline Pharmaceuticals, Stevenage, Herts, SG1 2NY, UK |
| |
| Abstract: | Modification of the benzo rings of 3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones into heteroaromatic systems was investigated to enhance physicochemical properties and potency profile of this class of inhibitors. The synthesis and biological activity of the derived compounds is discussed. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
